-
TD Cowen on Beta Bionics, Inc. (BBNX): 'our sense is the lift from here to address outstanding deficiencies is manageable'
-
TD Cowen Reiterates Hold Rating on Beta Bionics, Inc. (BBNX)
-
Beta Bionics, Inc. (BBNX) PT Lowered to $25 at Truist Securities
-
TD Cowen Starts Beta Bionics, Inc. (BBNX) at Hold
-
Beta Bionics, Inc. (BBNX) PT Raised to $40 at Lake Street Capital Markets
-
Beta Bionics (BBNX) Reiterated at Buy by Stifel: Expecting Revenue Upside
-
BofA Securities Downgrades Beta Bionics, Inc. (BBNX) to Neutral 'on new patient starts miss'
-
Stifel Reiterates Buy Rating on Beta Bionics, Inc. (BBNX)
-
Beta Bionics, Inc. (BBNX) PT Raised at Piper Sandler; 'No Sign of Momentum Slowing Anytime Soon'
-
Beta Bionics, Inc. (BBNX) PT Raised to $32 at Truist Securities
-
Beta Bionics, Inc. (BBNX) PT Raised to $33 at Goldman Sachs
-
Stifel Resumes Beta Bionics, Inc. (BBNX) at Buy
-
Truist: 'We Remain Bullish on Beta Bionics, Inc. (BBNX)'
-
Goldman Sachs Upgrades Beta Bionics, Inc. (BBNX) to Buy
-
Beta Bionics, Inc. (BBNX) PT Raised to $21 at Truist Securities
-
Beta Bionics, Inc. (BBNX) Tops Q2 EPS by 3c
-
Piper Sandler's Key MedTech Takeaways From ADA 2025
-
Truist Securities Starts Beta Bionics, Inc. (BBNX) at Buy
-
Goldman Sachs Starts Beta Bionics, Inc. (BBNX) at Neutral
-
Beta Bionics, Inc. (BBNX) Misses Q1 EPS by 51c
-
Stifel Reiterates Buy Rating on Beta Bionics, Inc. (BBNX)
-
Beta Bionics (BBNX) appoints Gerard Michel to Board
-
Piper Sandler Calls Beta Bionics, Inc. (BBNX) 'A Unique Diabetes Name to Own'
-
Stifel Reiterates Buy Rating on Beta Bionics, Inc. (BBNX)
-
Beta Bionics, Inc. (BBNX) Reports Q4 Loss of $2.72
-
BofA Securities Starts Beta Bionics, Inc. (BBNX) at Buy, 'iLet offers more autonomous insulin delivery'
-
Leerink Partners Starts Beta Bionics, Inc. (BBNX) at Outperform
-
Piper Sandler Starts Beta Bionics, Inc. (BBNX) at Overweight
-
Stifel Starts Beta Bionics, Inc. (BBNX) at Buy
-
Ladenburg Starts Beta Bionics, Inc. (BBNX) at Buy
-
Baird Starts Beta Bionics, Inc. (BBNX) at Neutral
-
Beta Bionic (BBNX) Files for 7.5M Share IPO at $14-$16/sh
-
Beta Bionic (BBNX) Files for Proposed IPO

